Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
FSD Pharma Inc Class B is a drug manufacturers-specialty & generic business based in the US. FSD Pharma Inc Class B shares (HUGE) are listed on the NASDAQ and all prices are listed in US Dollars. FSD Pharma Inc Class B employs 10 staff and has a market cap (total outstanding shares value) of 0.00.
Finder Award
SoFi Invest
tastyworks
| Latest market close | $0.97 |
|---|---|
| 52-week range | $0.62 - $1.11 |
| 50-day moving average | $0.87 |
| 200-day moving average | $0.89 |
| Wall St. target price | N/A |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.82 |
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.97 from 2023-01-26
| 1 week (2023-01-20) | 2.65% |
|---|---|
| 1 month (2022-12-28) | 30.03% |
| 3 months (2022-10-28) | 15.48% |
| 6 months (2022-07-28) | 3.74% |
| 1 year (2022-01-26) | 7.78% |
|---|---|
| 2 years (2021-01-28) | -53.37% |
| 3 years (2020-01-28) | 6.37 |
| 5 years (2018-01-24) | N/A |
| Gross profit TTM | $-3,331,945 |
|---|---|
| Return on assets TTM | -29.94% |
| Return on equity TTM | -55.49% |
| Profit margin | 0% |
| Book value | $0.95 |
| Market capitalisation | $36.7 million |
TTM: trailing 12 months
We're not expecting FSD Pharma Inc Class B to pay a dividend over the next 12 months.
FSD Pharma Inc Class B's shares were split on a 1:201 basis on 15 October 2019. So if you had owned 201 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your FSD Pharma Inc Class B shares – just the quantity. However, indirectly, the new 20000% higher share price could have impacted the market appetite for FSD Pharma Inc Class B shares which in turn could have impacted FSD Pharma Inc Class B's share price.
Over the last 12 months, FSD Pharma Inc Class B's shares have ranged in value from as little as $0.618 up to $1.11. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while FSD Pharma Inc Class B's is 0.9148. This would suggest that FSD Pharma Inc Class B's shares are less volatile than average (for this exchange).
FSD Pharma Inc. , a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD201, a palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma Inc. is headquartered in Toronto, Canada. .
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Learn about stock analysis and how to use it to find the right company to buy.
